Imunon Future Growth
Future criteria checks 0/6
Imunon's earnings are forecast to decline at 19.6% per annum while its annual revenue is expected to grow at 82.9% per year. EPS is expected to grow by 36% per annum.
Key information
-19.6%
Earnings growth rate
36.0%
EPS growth rate
Biotechs earnings growth | 36.7% |
Revenue growth rate | 82.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 23 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -35 | -45 | -46 | 4 |
12/31/2025 | N/A | -27 | -37 | -34 | 4 |
12/31/2024 | N/A | -22 | -29 | -29 | 4 |
6/30/2024 | N/A | -18 | -19 | -19 | N/A |
3/31/2024 | N/A | -19 | -21 | -21 | N/A |
12/31/2023 | N/A | -20 | -19 | -19 | N/A |
9/30/2023 | 0 | -28 | -21 | -20 | N/A |
6/30/2023 | 0 | -31 | -21 | -20 | N/A |
3/31/2023 | 0 | -31 | -19 | -19 | N/A |
12/31/2022 | 1 | -36 | -23 | -23 | N/A |
9/30/2022 | 1 | -27 | -23 | -23 | N/A |
6/30/2022 | 1 | -26 | -23 | -22 | N/A |
3/31/2022 | 1 | -26 | -20 | -19 | N/A |
12/31/2021 | 1 | -21 | -17 | -16 | N/A |
9/30/2021 | 1 | -20 | -15 | -15 | N/A |
6/30/2021 | 1 | -22 | -15 | -15 | N/A |
3/31/2021 | 1 | -22 | -16 | -15 | N/A |
12/31/2020 | 1 | -21 | -16 | -16 | N/A |
9/30/2020 | 1 | -22 | -18 | -18 | N/A |
6/30/2020 | 1 | -19 | -18 | -18 | N/A |
3/31/2020 | 1 | -20 | -20 | -20 | N/A |
12/31/2019 | 1 | -17 | -21 | -20 | N/A |
9/30/2019 | 1 | -8 | -9 | -9 | N/A |
6/30/2019 | 1 | -7 | -9 | -8 | N/A |
3/31/2019 | 1 | -10 | -8 | -8 | N/A |
12/31/2018 | 1 | -12 | -7 | -7 | N/A |
9/30/2018 | 1 | -22 | -17 | -17 | N/A |
6/30/2018 | 1 | -23 | -18 | -18 | N/A |
3/31/2018 | 1 | -20 | N/A | -18 | N/A |
12/31/2017 | 1 | -21 | N/A | -17 | N/A |
9/30/2017 | 1 | -21 | N/A | -17 | N/A |
6/30/2017 | 1 | -22 | N/A | -17 | N/A |
3/31/2017 | 1 | -21 | N/A | -17 | N/A |
12/31/2016 | 1 | -22 | N/A | -18 | N/A |
9/30/2016 | 1 | -22 | N/A | -18 | N/A |
6/30/2016 | 1 | -20 | N/A | -18 | N/A |
3/31/2016 | 1 | -21 | N/A | -20 | N/A |
12/31/2015 | 1 | -22 | N/A | -21 | N/A |
9/30/2015 | 1 | -23 | N/A | -23 | N/A |
6/30/2015 | 1 | -26 | N/A | -24 | N/A |
3/31/2015 | 1 | -27 | N/A | -22 | N/A |
12/31/2014 | 1 | -25 | N/A | -21 | N/A |
9/30/2014 | 1 | -23 | N/A | -18 | N/A |
6/30/2014 | 1 | -20 | N/A | -15 | N/A |
3/31/2014 | 1 | -13 | N/A | -16 | N/A |
12/31/2013 | 1 | -13 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0HUZ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0HUZ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0HUZ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0HUZ is forecast to have no revenue next year.
High Growth Revenue: 0HUZ is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0HUZ's Return on Equity is forecast to be high in 3 years time